Capricor Therapeutics
CAPR
#7976
Rank
โ‚น26.15 B
Marketcap
โ‚น572.02
Share price
-4.36%
Change (1 day)
-55.29%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น3.82 Billion

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are โ‚น3.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น2.14 B-28.65%
2023-12-31โ‚น3.00 B-5.11%
2022-12-31โ‚น3.17 B327.51%
2021-12-31โ‚น0.74 B57.95%
2020-12-31โ‚น0.46 B54.02%
2019-12-31โ‚น0.30 B-5.88%
2018-12-31โ‚น0.32 B0.49%
2017-12-31โ‚น0.32 B-79.16%
2016-12-31โ‚น1.54 B36.04%
2015-12-31โ‚น1.13 B-9.8%
2014-12-31โ‚น1.26 B235.84%
2013-12-31โ‚น0.37 B1194.9%
2012-12-31โ‚น28.97 M1.16%
2011-12-31โ‚น28.64 M-40.21%
2010-12-31โ‚น47.9 M61.94%
2009-12-31โ‚น29.58 M-53.79%
2008-12-31โ‚น64.01 M-13.67%
2007-12-31โ‚น74.14 M1142.17%
2006-12-31โ‚น5.96 M70.27%
2005-12-31โ‚น3.5 M36.28%
2004-12-31โ‚น2.57 M35.28%
2003-12-31โ‚น1.9 M61.49%
2002-12-31โ‚น1.17 M165.68%
2001-12-31โ‚น0.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
โ‚น176.07 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.90 B-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.211 T 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น113.51 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น4.50 B 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.23 B-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA